Philip Morris
Dow Nicorette
Fields
- Author
- Kay, A.J., J.R.
- Type
- MEMO, MEMORANDUM
- Document File
- 2023799679/2023799822/Operations 940000 - 860000
- Area
- PM USA/CARLSTADT
- Request
- Stmn/R1-004
- Stmn/R1-071
- Copied
- Campbell, W.J.
- Serrano, M.A.
- Named Organization
- Dow
- Site
- N308
- Named Person
- Resnik, F.E.
- Master ID
- 2023799789/9807
Related Documents:- 2023799789 Dow Nicorette
- 2023799790
- 2023799791
- 2023799792
- 2023799793-9794 If You Want to Quit for Good... Your Doctor Can Help
- 2023799796-9797 Dow - Nicorette Situation
- 2023799798 Merrell Dow Pharmaceutical Meeting - 820713
- 2023799799-9800 Suspension of Dow Purchases
- 2023799801-9802 Dow - Nicorette Meeting, 841023
- 2023799803 000118 Conference Call with Andrew Butler, Dow Chemical, A.J. Kay, Jr., R. D. Lathaw
- 2023799804
- 2023799805
- 2023799806
- 2023799807 If You Want to Quit Smoking for Good, See Your Doctor
- Litigation
- Stmn/Produced
- Author (Organization)
- PM, Philip Morris
- Recipient
- Resnik, F.E.
- Recipient (Organization)
- PM, Philip Morris
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- juk04e00
Document Images
PHILIP MORRIS U. S. A.
INTER-OFFICE CORRESPONDENCE
RICHMOND, VIRGINIA
To: . Mr. F. E. Resni k
From: . A. J. Kay, Jr.
Subject: . Dow Nicorette
R ECE I VED'
SEP 9 1985
FRANK E. RESNIK
Date: September 6, 1985
Attached are excerpts from our rather lengthy file on the
subject of the marketing of Nicorette by Dow. The file indicates the
ongoing efforts to "tone down" the marketing strategies of Nicorette.
I believe we have made some progress, but it still remains
irritating that a subsidiary of one of our suppliers continues to
sell a product that directly impacts on the sale of our product. We
feel that we do need Dow as a suppl i er of humectants and that i t
would be more expeditious to have influence on Dow in this matter as
a customer.
You mentioned that you may take action on your own such as a
letter to Dow expressing your displeasure with events. Most of our
discussions with Dow have been over a conference table and not
correspondence. If you will recall some time ago, Dow requested an
audience with you and the decision was to keep it at a lower level.
After you have reviewed the file, it may be better to have a top
level discussion in New York. Please advise.
AJK/jw
cc: W. J. Campbell
M. A. Serrano
